ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug candidate CBX-12 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard therapies. The main goals were to check the drug's safety, find the best dose, and see if it could sh…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immunotherapy combo shows promise for inoperable esophageal cancer
Disease control CompletedThis Phase 2 trial tested whether adding the immunotherapy drug durvalumab to standard chemoradiation (FOLFOX and radiation) helps patients with unresectable esophageal cancer. 112 patients were randomly assigned to receive either chemoradiation alone or chemoradiation plus durva…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC